Suzanne Ildstad, Director at Talaris Therapeutics, Inc. (TALS), sold 6,551 shares at $2.05 ($13K) on 2023-02-17, disclosed to the SEC on 2023-02-21.
Open-market sale of $13k TALS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.06 | 2,939 | $6K | 45.0% |
| 2 | $2.05 | 3,612 | $7K | 55.0% |
| Total | $2.05 avg | 6,551 | $13K | 100% |
| Filing → |
| TALS | SELL | 2023-06-07 | $149K | — | Filing → |
| TALS | SELL | 2023-06-05 | $80K | — | Filing → |
| TALS | SELL | 2023-04-25 | $35K | — | Filing → |